FORM (by GBY) review

The choice here is breadth rather than a low-dose price — one of the broadest menus anywhere on this site, compounded and brand-name semaglutide and tirzepatide, a named compounded microdose tirzepatide product, NAD+, sermorelin and a hair-loss line, all under one login. The microdose tirzepatide product is exactly what a low-dose reader is looking for, but its price is not published anywhere on the public site, and neither is the price of standard tirzepatide, Zepbound, or any of the longevity add-ons. The one figure that is visible on the Wegovy line is a membership fee only; the medication itself is billed separately and that cost never appears on the page, so it should never be read as an all-in brand price.

Vs median

$130/mo above the $169 median across the 261 of 407 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

No low-dose price published

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

FORM (by GBY) does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

FORM by GBY (a Las Vegas, NV entity) runs the widest multi-vertical menu here: compounded semaglutide and tirzepatide in injectable and oral form, branded Wegovy and Zepbound memberships, a named compounded microdose tirzepatide product, NAD+/sermorelin/GHK-Cu/glutathione, and a separate hair-loss line. For a microdose reader the named product is the draw, but almost nothing beyond the base semaglutide rate is priced on the public site — tirzepatide, microdose tirzepatide, Zepbound and the longevity add-ons all sit behind the intake. The one number that is visible, the "$95/mo" Wegovy figure, is a membership fee only; the actual drug cost is billed on top and is not shown anywhere on the page, so it should never be read as an all-in Wegovy price.

No published price for the microdose tirzepatide product itself, or for standard tirzepatide, Zepbound, NAD+ or the hair-loss line — a microdoser cannot cost the one product that makes this listing relevant before starting an intake

• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
• The advertised "$95/mo" Wegovy figure is a membership fee only — the medication cost is charged separately and is not disclosed on the site, so it should not be read as the all-in brand price
• Does not serve Alaska or Mississippi
• No named doctors, medical director, or compounding pharmacy disclosed anywhere on the site

FORM (by GBY) is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Microdosing tirzepatide
• Is compounded GLP-1 safe?
• Microdose & reconstitution calculator
• Titration planner